Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Epigenomics

• Publication date

  2013-09-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/epi.13.56PMID 24059799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetic inactivation of the MIR129-2 in hematological malignancies

  2013cited by this paper
• Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381)

  2013cited by this paper
• HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity

  2013cited by this paper
• Differential mRNA Expression Levels of Human Histone-Modifying Enzymes in Normal Karyotype B Cell Pediatric Acute Lymphoblastic Leukemia

  2013cited by this paper
• Effects of down-regulation of HDAC6 expression on proliferation, cell cycling and migration of esophageal squamous cell carcinoma cells and related molecular mechanisms.

  2013cited by this paper
• Epigenetic therapy of hematological malignancies: where are we now?

  2013cited by this paper
• Synergistic Activity of Bortezomib and HDACi in Preclinical Models of B-cell Precursor Acute Lymphoblastic Leukemia via Modulation of p53, PI3K/AKT, and NF-κB

  2013cited by this paper
• GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia

  2013cited by this paper
• An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

  2013cited by this paper
• Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.

  2013cited by this paper
• Hypomethylation of the CTGF gene locus is a common feature of paediatric pre‐B acute lymphoblastic leukaemia

  2013cited by this paper
• Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.

  2012cited by this paper
• Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed.

  2012cited by this paper
• HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins

  2012cited by this paper
• Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia

  2012cited by this paper
• Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity

  2012cited by this paper
• Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia

  2012cited by this paper
• Epigenetic Drug Discovery

  2012cited by this paper
• Global DNA hypomethylation in cancer: review of validated methods and clinical significance

  2012cited by this paper
• Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy

  2012cited by this paper
• T‐cell acute lymphoblastic leukaemia: recent molecular biology findings

  2012cited by this paper
• DNA methylation pattern is altered in childhood T-cell acute lymphoblastic leukemia patients as compared with normal thymic subsets: insights into CpG island methylator phenotype in T-ALL

  2012cited by this paper
• Preclinical activity of LBH 589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia

  2012cited by this paper
• Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.

  2012cited by this paper
• The complex world of WNT receptor signalling

  2012cited by this paper
• Epigenetics and blood disorders

  2012cited by this paper
• CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia

  2012cited by this paper
• Aberrant methylation and decreased expression of the RIZ1 gene are frequent in adult acute lymphoblastic leukemia of T-cell phenotype

  2012cited by this paper
• DNA Methylation Analysis of Bone Marrow Cells at Diagnosis of Acute Lymphoblastic Leukemia and at Remission

  2012cited by this paper
• Emerging Pharmacotherapies for Adult Patients with Acute Lymphoblastic Leukemia

  2012cited by this paper
• Wnt/β-catenin signaling and disease.

  2012cited by this paper
• Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia

  2012cited by this paper
• Molecular genetics of B-precursor acute lymphoblastic leukemia.

  2012cited by this paper
• Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia

  2012cited by this paper
• DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.

  2012cited by this paper
• Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents

  2012cited by this paper
• The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

  2012cited by this paper
• Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia

  2012cited by this paper
• Trials with ‘epigenetic’ drugs: An update

  2012cited by this paper
• A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia.

  2012cited by this paper
• CREBBP mutations in relapsed acute lymphoblastic leukaemia

  2011cited by this paper
• Epigenetic aberrations during oncogenesis

  2011cited by this paper
• Histone lysine methylation and demethylation pathways in cancer.

  2011cited by this paper
• Epigenomics of leukemia: from mechanisms to therapeutic applications.

  2011cited by this paper
• Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy

  2011cited by this paper
• Co-Regulation of Histone-Modifying Enzymes in Cancer

  2011cited by this paper
• Promoter methylation‐mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance

  2011cited by this paper
• Aberrant Regulation of HDAC2 Mediates Proliferation of Hepatocellular Carcinoma Cells by Deregulating Expression of G1/S Cell Cycle Proteins

  2011cited by this paper
• From Waddington’s epigenetic landscape to small noncoding RNA: some important milestones in the history of epigenetics research

  2011cited by this paper
• Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy

  2011cited by this paper
• Frequent and Simultaneous Epigenetic Inactivation of TP53 Pathway Genes in Acute Lymphoblastic Leukemia

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• The role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-Myc

  2011cited by this paper
• HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo

  2011cited by this paper
• Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia.

  2011cited by this paper
• Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia.

  2011cited by this paper
• Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)

  2011cited by this paper
• p53-independent Epigenetic Repression of the p21WAF1 Gene in T-cell Acute Lymphoblastic Leukemia*

  2011cited by this paper
• Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family

  2011cited by this paper
• Genetic Inactivation of the PRC2 Complex in T-Cell Acute Lymphoblastic Leukemia

  2011cited by this paper
• Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers

  2010cited by this paper
• Efficacy of MK-0457 and in combination with vorinostat against Philadelphia chromosome positive acute lymphoblastic leukemia cells

  2010cited by this paper
• The Clinical Implications of Methylated p15 and p73 Genes in Adult Acute Lymphoblastic Leukemia.

  2010cited by this paper
• Regulation of the Apaf-1–caspase-9 apoptosome

  2010cited by this paper
• The Clinical Implications of Methylated p15 and p73 Genes in Adult Acute Lymphoblastic Leukemia.

  2010cited by this paper
• Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia

  2010cited by this paper
• Leukaemogenesis: more than mutant genes

  2010cited by this paper
• Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2.

  2010cited by this paper
• Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 .

  2010cited by this paper
• HAT trick: p300, small molecule, inhibitor.

  2010cited by this paper
• Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors.

  2010cited by this paper
• A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers

  2010cited by this paper
• Leukaemogenesis: more than mutant genes

  2010cited by this paper
• Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia

  2010cited by this paper
• research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia

  2010cited by this paper
• DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.

  2010cited by this paper
• Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

  2010cited by this paper
• Eph receptors and ephrins in cancer: bidirectional signalling and beyond

  2010cited by this paper
• Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.

  2010cited by this paper
• Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy

  2010cited by this paper
• Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development

  2010cited by this paper
• Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches†

  2010cited by this paper
• Adult acute lymphoblastic leukemia

  2010cited by this paper
• Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.

  2010cited by this paper
• Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.

  2009cited by this paper
• The DNA methylome of pediatric acute lymphoblastic leukemia.

  2009cited by this paper
• Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.

  2009cited by this paper
• Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program

  2009cited by this paper
• Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia

  2009cited by this paper
• Identification of cell-active lysine specific demethylase 1-selective inhibitors.

  2009cited by this paper
• The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias

  2009cited by this paper
• HDAC family: What are the cancer relevant targets?

  2009cited by this paper
• Histone deacetylase inhibitors in cancer therapy.

  2009cited by this paper
• Anti‐leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro

  2009cited by this paper
• The molecular biology of mixed lineage leukemia

  2009cited by this paper
• Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia

  2009cited by this paper
• Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemia

  2009cited by this paper
• Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.

  2009cited by this paper
• Acute lymphoblastic leukaemia.

  2008cited by this paper
• Clinical Trials and Observations

  2008cited by this paper

• Multi-Omics Approaches to Understanding Therapy Resistance in Acute Lymphoblastic Leukemia

  2026cites this paper
• MIR4435-2HG as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL

  2024cites this paper
• Epigenetics changes affecting L-asparaginase therapy in human leukemia: a mini review

  2021cites this paper
• Promoter Methylation Status and Expression Levels of RASSF1A Gene in Different Phases of Acute Lymphoblastic Leukemia (ALL)

  2021cites this paper
• Relation between tumor micro-environment and epigenetic alterations in hematological malignancies

  2021cites this paper
• Therapeutic Interaction of Apatinib and Chidamide in T-cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis

  2021cites this paper
• Is the effect of Decitabine limited to hypomethylation and DNMTs?

  2019cites this paper
• The effect of decitabine on the expression and methylation of the PPP1CA, BTG2, and PTEN in association with changes in miR‐125b, miR‐17, and miR‐181b in NALM6 cell line

  2019cites this paper
• New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update

  2018cites this paper
• Epigenetic alterations in acute lymphoblastic leukemia

  2017cites this paper
• Phytochemicals as an adjuvant in leukemia therapy

  2017cites this paper
• Implicación de las alteraciones en el número de copias en el pronóstico y progresión de la leucemia aguda linfoblástica de línea B del adulto

  2017cites this paper
• The epigenetic effect of microRNA in BCR-ABL1‑positive microvesicles during the transformation of normal hematopoietic transplants.

  2017cites this paper
• [Epigenetic alterations in acute lymphoblastic leukemia].

  2017cites this paper
• Twist as a new prognostic marker in hematological malignancies

  2016cites this paper
• Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis

  2015cites this paper
• etection and analysis of tumour biomarkers to trengthen the diagnosis of acute and chronic eukaemias

  2015cites this paper
• Detection and analysis of tumour biomarkers to strengthen the diagnosis of acute and chronic leukaemias

  2015cites this paper
• Comparative epigenomic analysis of bone tissue and primary osteoblasts

  2014cites this paper
• Análisis comparativo del epigenoma del tejido óseo y de osteoblastos primarios

  2014cites this paper